| Identical sales growth | 2.4% | CFO,Q3,净影响含政府停摆/SNAP延迟10–20bps |
| Digital sales growth | 21% | CEO/CFO,Q3 |
| Pharmacy/Health sales growth | 18% | CFO,Q3 |
| Gross margin(不含燃油/LIFO) | 27.4% | CFO,Q3,同比-55bps |
| SG&A rate(不含燃油) | 24.9% | CFO,Q3,同比-33bps |
| Adjusted EBITDA | $1.039B | CFO/CEO,Q3 |
| Adjusted EPS | $0.72 | CFO,Q3 |
| CapEx | $462M | CFO,Q3 |
| Dividends returned | $77M | CFO,Q3 |
| Net debt / adjusted EBITDA | 2.29x | CFO,季末 |
| Loyalty membership | 49.8M | CFO,Q3,同比+12% |
| E-commerce penetration | 9.5% | CEO,Q3 |
| FY25 identical sales guidance | 2.2%–2.5% | CFO,全年,含IRA影响 |
| FY25 Adjusted EBITDA guidance | $3.825B–$3.875B | CFO,全年,含第53周约$65M |
| FY25 Adjusted EPS guidance | $2.08–$2.16 | CFO,全年 |
| FY25 CapEx guidance | $1.8B–$1.9B | CFO,不变 |